Angela Webster

Last updated

Professor Angela Webster FAHMS is a clinical epidemiologist at the Sydney School of Public Health, University of Sydney, nephrologist and transplant physician at Westmead Hospital and director of Evidence Integration at the NHMRC Clinical Trials Centre, University of Sydney.

Contents

Biography

Webster is a clinical academic with a focus on transplant medicine, kidney disease and epidemiology.

Webster's research themes include multimorbidity and the interaction of chronic diseases, specifically kidney disease, cancer, cardiovascular disease, diabetes, infection, and mental illness, addressed through evidence integration. Her researched is focused on improving clinical outcomes and using data to improve clinical decision making, by communicating and evaluating risk. She has a particular interest in health inequalities and mitigating factors that create disadvantage in health and healthcare settings.

Select publications

YearTitleJournalRef
2017Chronic Kidney DiseaseThe Lancet [1]
2021Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage studyBMJ [2]
2016Cognition in chronic kidney disease: a systematic review and meta-analysisBiomed Central Medicine. [3]
2015Readability of Written Materials for CKD Patients: A Systematic Review.American Journal of Kidney Diseases [4]
2021Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease.Health Promotion Journal of Australia [5]
2019Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.Medical Journal of Australia [6]
2014Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort studyAmerican Journal of Transplantation [7]
2021The landscape of COVID-19 trials in AustraliaMedical Journal of Australia. [8]
2022Searching clinical trials registers: guide for systematic reviewers.BMJ [9]
2013Interventions for smoking cessation and reduction in individuals with schizophreniaCochrane Database of Systematic Reviews [10]

Awards

YearAwardOrganisationRef
2023Elected as Fellow of the Australian Academy of Health and Medical SciencesAustralian Academy of Health and Medical Sciences [11]
2020TJ Neale Award for Outstanding Contribution to Nephrological ScienceAustralian and New Zealand Society of Nephrology
2019Josette Eris Memorial Award for emerging female leadersTransplantation Society of Australia and New Zealand
2015Ian McKenzie Prize for outstanding contribution in transplantationTransplantation Society of Australia and New Zealand

Related Research Articles

<span class="mw-page-title-main">ACE inhibitor</span> Class of medications used primarily to treat high blood pressure

Angiotensin-converting-enzyme inhibitors are a class of medication used primarily for the treatment of high blood pressure and heart failure. This class of medicine works by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.

<span class="mw-page-title-main">Proton-pump inhibitor</span> Class of drugs for reducing stomach acid

Proton-pump inhibitors (PPIs) are a class of medications that cause a profound and prolonged reduction of stomach acid production. They do so by irreversibly inhibiting the stomach's H+/K+ ATPase proton pump.

<span class="mw-page-title-main">Gout</span> Form of arthritis causing swollen joints

Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot and swollen joint, caused by the deposition of needle-like crystals of uric acid known as monosodium urate crystals. Pain typically comes on rapidly, reaching maximal intensity in less than 12 hours. The joint at the base of the big toe is affected (Podagra) in about half of cases. It may also result in tophi, kidney stones, or kidney damage.

<span class="mw-page-title-main">Kidney dialysis</span> Removal of nitrogenous waste and toxins from the body in place of or to augment the kidney

Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy. The first successful dialysis was performed in 1943.

<span class="mw-page-title-main">Kidney disease</span> Damage to or disease of a kidney

Kidney disease, or renal disease, technically referred to as nephropathy, is damage to or disease of a kidney. Nephritis is an inflammatory kidney disease and has several types according to the location of the inflammation. Inflammation can be diagnosed by blood tests. Nephrosis is non-inflammatory kidney disease. Nephritis and nephrosis can give rise to nephritic syndrome and nephrotic syndrome respectively. Kidney disease usually causes a loss of kidney function to some degree and can result in kidney failure, the complete loss of kidney function. Kidney failure is known as the end-stage of kidney disease, where dialysis or a kidney transplant is the only treatment option.

<span class="mw-page-title-main">Chronic kidney disease</span> Medical condition

Chronic kidney disease (CKD) is a type of kidney disease in which a gradual loss of kidney function occurs over a period of months to years. Initially generally no symptoms are seen, but later symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications can relate to hormonal dysfunction of the kidneys and include high blood pressure, bone disease, and anemia. Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization.

<span class="mw-page-title-main">Xenotransplantation</span> Transplantation of cells or tissue across species

Xenotransplantation, or heterologous transplant, is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. It is contrasted with allotransplantation, syngeneic transplantation or isotransplantation and autotransplantation. Xenotransplantation is an artificial method of creating an animal-human chimera, that is, a human with a subset of animal cells. In contrast, an individual where each cell contains genetic material from a human and an animal is called a human–animal hybrid.

<span class="mw-page-title-main">Polyneuropathy</span> Medical condition

Polyneuropathy is damage or disease affecting peripheral nerves in roughly the same areas on both sides of the body, featuring weakness, numbness, and burning pain. It usually begins in the hands and feet and may progress to the arms and legs and sometimes to other parts of the body where it may affect the autonomic nervous system. It may be acute or chronic. A number of different disorders may cause polyneuropathy, including diabetes and some types of Guillain–Barré syndrome.

<span class="mw-page-title-main">Renal artery stenosis</span> Medical condition

Renal artery stenosis (RAS) is the narrowing of one or both of the renal arteries, most often caused by atherosclerosis or fibromuscular dysplasia. This narrowing of the renal artery can impede blood flow to the target kidney, resulting in renovascular hypertension – a secondary type of high blood pressure. Possible complications of renal artery stenosis are chronic kidney disease and coronary artery disease.

<span class="mw-page-title-main">Kidney transplantation</span> Medical procedure

Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient. The first successful kidney transplant was performed in 1954 by a team including Joseph Murray, the recipient’s surgeon, and Hartwell Harrison, surgeon for the donor. Murray was awarded a Nobel Prize in Physiology or Medicine in 1990 for this and other work. In 2018, an estimated 95,479 kidney transplants were performed worldwide, 36% of which came from living donors.

<span class="mw-page-title-main">Lupus nephritis</span> Inflammation of the kidneys

Lupus nephritis is an inflammation of the kidneys caused by systemic lupus erythematosus (SLE), an autoimmune disease. It is a type of glomerulonephritis in which the glomeruli become inflamed. Since it is a result of SLE, this type of glomerulonephritis is said to be secondary, and has a different pattern and outcome from conditions with a primary cause originating in the kidney. The diagnosis of lupus nephritis depends on blood tests, urinalysis, X-rays, ultrasound scans of the kidneys, and a kidney biopsy. On urinalysis, a nephritic picture is found and red blood cell casts, red blood cells and proteinuria is found.

<span class="mw-page-title-main">History of chronic fatigue syndrome</span> Review of the topic

Chronic fatigue syndrome has a long history with an evolution in medical understanding, diagnoses and social perceptions.

<span class="mw-page-title-main">Chronic fatigue syndrome</span> Medical condition

Chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME) or ME/CFS, is a debilitating long-term medical condition. People with ME/CFS experience lengthy flare-ups of the illness following relatively minor physical or mental activity. This is known as post-exertional malaise (PEM) and is the hallmark symptom of the illness. Other core symptoms are a greatly reduced ability to do tasks that were previously routine, severe fatigue, and sleep disturbances. The baseline fatigue in ME/CFS does not improve much with rest. Orthostatic intolerance, memory and concentration problems, and chronic pain are common. About a quarter of people with ME/CFS are severely affected and unable to leave their bed or home.

<span class="mw-page-title-main">Health effects of salt</span> Conditions associated with the consumption of either too much or too little salt

The health effects of salt are the conditions associated with the consumption of either too much or too little salt. Salt is a mineral composed primarily of sodium chloride (NaCl) and is used in food for both preservation and flavor. Sodium ions are needed in small quantities by most living things, as are chloride ions. Salt is involved in regulating the water content of the body. The sodium ion itself is used for electrical signaling in the nervous system.

<span class="mw-page-title-main">Transplant glomerulopathy</span> Medical condition

Transplant glomerulopathy(TG) is a morphologic lesion of renal allografts that is histologically identified by glomerular basement membrane (GBM) duplication and/or multilayering. Proteinuria, hypertension, and deteriorating graft function are the hallmarks of TG.

Mesoamerican nephropathy (MeN) is an endemic, non-diabetic, non-hypertensive chronic kidney disease (CKD) characterized by reduced glomerular filtration rate (GFR) with mild or no proteinuria and no features of known primary glomerular diseases. MeN is prevalent in agricultural communities along the Pacific Ocean coastal lowlands Mesoamerica, including southern Mexico, Guatemala, El Salvador, Nicaragua, Honduras and Costa Rica. Although most cases have been described among agricultural workers, MeN has also been described in other occupations, including miners, brick manufacturers, and fishermen. A common denominator among these occupations is that they are outdoor workers who reside in rural areas in hot and humid climates.

Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.

The male-female health-survival paradox, also known as the morbidity-mortality paradox or gender paradox, is the phenomenon in which female humans experience more medical conditions and disability during their lives, but they unexpectedly live longer than males. This paradox, where females experience greater morbidity (diseases) but lower mortality (death) in comparison to males, is unusual since it is expected that experiencing disease increases the likelihood of death. However, in this case, the part of the population that experiences more disease and disability is the one that lives longer.

A renal diet is a diet aimed at keeping levels of fluids, electrolytes, and minerals balanced in the body in individuals with chronic kidney disease or who are on dialysis. Dietary changes may include the restriction of fluid intake, protein, and electrolytes including sodium, phosphorus, and potassium. Calories may also be supplemented if the individual is losing weight undesirably.

<span class="mw-page-title-main">Marjorie Bick</span> Australian woman biochemist

Marjorie Elizabeth Dulcie Bick was an Australian biochemist.

References

  1. Webster, Angela C; Nagler, Evi V; Morton, Rachael L; Masson, Philip (March 2017). "Chronic Kidney Disease". The Lancet. 389 (10075): 1238–1252. doi:10.1016/S0140-6736(16)32064-5. PMID   27887750. S2CID   4925820.
  2. De La Mata, Nicole L; Rosales, Brenda; MacLeod, Grace; Kelly, Patrick J; Masson, Philip; Morton, Rachael L; Wyburn, Kate; Webster, Angela C (2021-11-16). "Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study". BMJ. 375: e068247. doi: 10.1136/BMJ-2021-068247 . ISSN   1756-1833. PMC   8593820 . PMID   34785509.
  3. Berger, Israel; Wu, Sunny; Masson, Philip; Kelly, Patrick J.; Duthie, Fiona A.; Whiteley, William; Parker, Daniel; Gillespie, David; Webster, Angela C. (December 2016). "Cognition in chronic kidney disease: a systematic review and meta-analysis". BMC Medicine. 14 (1): 206. doi: 10.1186/s12916-016-0745-9 . ISSN   1741-7015. PMC   5155375 . PMID   27964726.
  4. Morony, Suzanne; Flynn, Michaela; McCaffery, Kirsten J.; Jansen, Jesse; Webster, Angela C. (June 2015). "Readability of Written Materials for CKD Patients: A Systematic Review". American Journal of Kidney Diseases. 65 (6): 842–850. doi:10.1053/j.ajkd.2014.11.025. hdl: 2123/22350 . PMID   25661679.
  5. Muscat, Danielle Marie; Lambert, Kelly; Shepherd, Heather; McCaffery, Kirsten J.; Zwi, Stephanie; Liu, Na; Sud, Kamal; Saunders, John; O’Lone, Emma; Kim, Jinman; Robbins, Aphra; Webster, Angela C. (February 2021). Smith, James (ed.). "Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease". Health Promotion Journal of Australia. 32 (S1): 115–127. doi: 10.1002/hpja.416 . ISSN   1036-1073. PMID   32888215.
  6. Waller, Karen MJ; De La Mata, Nicole L; Kelly, Patrick J; Ramachandran, Vidiya; Rawlinson, William D; Wyburn, Kate R; Webster, Angela C (November 2019). "Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis". Medical Journal of Australia. 211 (9): 414–420. doi:10.5694/mja2.50315. ISSN   0025-729X. PMID   31489635. S2CID   201846138.
  7. Vajdic, C.M.; Chong, A.H.; Kelly, P.J.; Meagher, N.S.; Van Leeuwen, M.T.; Grulich, A.E.; Webster, A.C. (June 2014). "Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study" . American Journal of Transplantation. 14 (6): 1368–1375. doi:10.1111/ajt.12716. PMID   24730453. S2CID   7791631.
  8. Seidler, Anna Lene; Aberoumand, Mason; Williams, Jonathan G; Tan, Aidan; Hunter, Kylie E; Webster, Angela (2021-07-19). "The landscape of COVID-19 trials in Australia". Medical Journal of Australia. 215 (2): 58–61.e1. doi:10.5694/mja2.51148. ISSN   0025-729X. PMC   8447014 . PMID   34275134.
  9. Hunter, Kylie E; Webster, Angela C; Page, Matthew J; Willson, Melina; McDonald, Steve; Berber, Slavica; Skeers, Peta; Tan-Koay, Ava G; Parkhill, Anne; Seidler, Anna Lene (2022-04-26). "Searching clinical trials registers: guide for systematic reviewers". BMJ. 377: e068791. doi: 10.1136/bmj-2021-068791 . ISSN   1756-1833. PMID   35473822.
  10. Tsoi, Daniel T; Porwal, Mamta; Webster, Angela C (2013-02-28). Cochrane Tobacco Addiction Group (ed.). "Interventions for smoking cessation and reduction in individuals with schizophrenia". Cochrane Database of Systematic Reviews. 2013 (2): CD007253. doi:10.1002/14651858.CD007253.pub3. PMC   6486303 . PMID   23450574.
  11. Tamowicz, Celeste (2023-10-12). "Professor Angela Webster". Australian Academy of Health and Medical Sciences. Retrieved 2023-11-24.